Canada markets closed

EyeGene Inc. (185490.KQ)

KOSDAQ - KOSDAQ Delayed Price. Currency in KRW
Add to watchlist
2,995.00-135.00 (-4.31%)
At close: 03:30PM KST
Currency in KRW

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.73
52-Week Change 3-27.63%
S&P500 52-Week Change 325.26%
52 Week High 34,895.00
52 Week Low 32,800.00
50-Day Moving Average 33,168.90
200-Day Moving Average 33,350.65

Share Statistics

Avg Vol (3 month) 374.69k
Avg Vol (10 day) 344.79k
Shares Outstanding 510.99M
Implied Shares Outstanding 6N/A
Float 819.45M
% Held by Insiders 128.02%
% Held by Institutions 10.13%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21.2:1
Last Split Date 3Jun 28, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-307.81%

Management Effectiveness

Return on Assets (ttm)-21.36%
Return on Equity (ttm)-33.66%

Income Statement

Revenue (ttm)3.13B
Revenue Per Share (ttm)144.39
Quarterly Revenue Growth (yoy)-5.50%
Gross Profit (ttm)N/A
EBITDA -24.95B
Net Income Avi to Common (ttm)-21.11B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)55.37B
Total Cash Per Share (mrq)2,048.41
Total Debt (mrq)3.21B
Total Debt/Equity (mrq)4.99%
Current Ratio (mrq)9.33
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-20.07B
Levered Free Cash Flow (ttm)-13.59B